The problem
Employers can't get every employee, worldwide, to the right level of mental health care at a predictable cost
What they do
Employer mental health benefit: coaching, therapy, psychiatry, groups and digital tools in one app
Traction ~$175M revenue (2024 est.); 184% 3-yr revenue growth (Inc. 5000 2025); 200+ countries
Hiring trend
- Open roles
- 7
- Ops roles
- 2
- Headcount
- ~600-920 (est.)
Flat: ~920 on LinkedIn (854 Dec 2024 → 922 Nov 2025, incl. care staff); only 5 open roles, all remote US
Hiring in
- Remote (US)
Latest news
Sep 2026
Published global research: employees want coaching and manager support, not only therapy ↗Glassdoor
3.3 ★ 155 reviews ↗Funding
- Last round
- $74M
- Stage
- Series D
- Date
- Feb 2021
Led by Founders Fund
- Hiring+17 open roles on the live job board (3–9 roles = +1)
- Funding recency0Series D · $74M, Feb 2021 (68 months ago): over 24 months = 0
- Traction+0.75Some growth: ~$175M revenue (2024 est.); 184% 3-yr revenue growth (Inc. 5000 2025); 200+ countries
- Red flags0Watch-outs noted below, none scored as a significant flag
- Total1.751 + 0 + 0.75 − 0 = 1.75 → Steady (1.5–3.49)
Distance (10K) is a separate read on how long the lead can last. It doesn't change the score.
Distance
10K · edge: hard to leave
A real, scaled employer benefit (~$175M revenue est., global network) but a #3-4 follower in a consolidating category: Lyra ($5.58B) and Spring (now with Alma) are bigger and still raising and acquiring, while Modern Health hasn't priced a round since 2021.
Sources: GetLatka: Modern Health ~$174.6M revenue est. vs Spring, Lyra (Sep 2026) ↗ · Behavioral Health Business: Inc. 5000 2025, Modern Health 184% growth, $100M-$250M range ↗ · Fierce Healthcare: Lyra Health $235M at $5.58B valuation ↗
Watch-outs
Watch (not scored): no priced round since the $74M Series D at $1.17B (Feb 2021), only a ~$21.5M mezzanine deal in Feb 2023 while Lyra and Spring raised and bought rivals; two layoff rounds in 2023 (~170 people, outside the 24-mo window); founder-CEO stepped aside for Matt Levin (Apr 2025); Glassdoor 3.3 with low senior-management scores.
Sources: Modern Health: $74M Series D at $1.17B valuation (Feb 2021) ↗ · PitchBook: Modern Health profile, $21.5M mezzanine (Feb 2023) ↗ · TrueUp: Modern Health layoffs (Jan and Jun 2023, ~170 impacted) ↗ · Business Wire via Morningstar: Matt Levin named CEO, founder to Executive Chair (Apr 2025) ↗ · Glassdoor: Modern Health reviews (3.3, 155 reviews) ↗
Open ops roles · 2
Last checked Oct 25, 2026